Spero Therapeutics, Inc. Common Stock (SPRO) is a publicly traded Healthcare sector company. As of July 15, 2026, SPRO trades at $1.82 with a market cap of $121.59M and a P/E ratio of 7.91. SPRO moved -17.89% today. Year to date, SPRO is -3.96%; over the trailing twelve months it is -22.42%. Its 52-week range spans $0.51 to $3.22. Rallies surfaces SPRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $1.82 |
| Market Cap | $121.59M |
| P/E Ratio | 7.91 |
| EPS | $0.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.22 |
| 52-Week Low | $0.51 |
| Volume | 9.11M |
| Avg Volume | 0 |
| Revenue (TTM) | $61.19M |
| Net Income | $15.23M |
| Gross Margin | 0.00% |
SPRO analyst coverage data. Average price target: $0.00.